Peter Rieckmann

Peter Rieckmann

UNVERIFIED PROFILE

Are you Peter Rieckmann?   Register this Author

Register author
Peter Rieckmann

Peter Rieckmann

Publications by authors named "Peter Rieckmann"

Are you Peter Rieckmann?   Register this Author

100Publications

1632Reads

50Profile Views

Benefit-risk Assessment of Cladribine Using Multi-criteria Decision Analysis (MCDA) for Patients With Relapsing-remitting Multiple Sclerosis.

Clin Ther 2019 Feb;41(2):249-260.e18

Department of Management, London School of Economics and Political Science, London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2018.12.015DOI Listing
February 2019

Patient Power Revolution in Multiple Sclerosis: Navigating the New Frontier.

Neurol Ther 2018 Dec 9;7(2):179-187. Epub 2018 Nov 9.

Royal Holloway, University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40120-018-0118-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283799PMC
December 2018

The use of satellite data to measure ultraviolet-B penetrance and its potential association with age of multiple sclerosis onset.

Mult Scler Relat Disord 2018 Apr 6;21:30-34. Epub 2018 Feb 6.

Division of Neurology, Faculty of Medicine and the Djavad Mowafaghian Centre for Brain Health, University of British Columbia, 2221 Wesbrook Mall, Vancouver, Canada V6T 2B5. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2018.02.005DOI Listing
April 2018

Electrophysiological assessment of nociception in patients with Parkinson's disease: A multi-methods approach.

J Neurol Sci 2016 Sep 28;368:59-69. Epub 2016 Jun 28.

University of Bamberg, Department of Physiological Psychology, Bamberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2016.06.058DOI Listing
September 2016

Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis.

Acta Neuropathol Commun 2016 08 8;4(1):81. Epub 2016 Aug 8.

Department of Neuropathology, University Medical Center Göttingen, Georg-August-University, Robert-Koch-Str. 40, 37075, Göttingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40478-016-0352-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977646PMC
August 2016

SPARC expression by cerebral microvascular endothelial cells in vitro and its influence on blood-brain barrier properties.

J Neuroinflammation 2016 08 31;13(1):225. Epub 2016 Aug 31.

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12974-016-0657-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007716PMC
August 2016

Genome-wide significant association with seven novel multiple sclerosis risk loci.

J Med Genet 2015 Dec 16;52(12):848-55. Epub 2015 Oct 16.

Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany Department of Medicine, School of Public Health, Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmedgenet-2015-103442DOI Listing
December 2015

Does Parkinson's disease lead to alterations in the facial expression of pain?

J Neurol Sci 2015 Dec 31;359(1-2):226-35. Epub 2015 Oct 31.

University of Bamberg, Department of Physiological Psychology, Bamberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2015.10.056DOI Listing
December 2015

Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naïve T cells.

J Autoimmun 2014 Aug 24;52:122-9. Epub 2013 Dec 24.

Institute of Pathology, University of Würzburg, Würzburg, Germany; Institute of Pathology, University Medical Centre Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, D-68135 Mannheim, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaut.2013.12.006DOI Listing
August 2014

Multiple sclerosis in the Arabian Gulf countries: a consensus statement.

J Neurol 2013 Dec 17;260(12):2959-63. Epub 2013 Mar 17.

King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-013-6876-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843364PMC
December 2013

Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis.

Ann Neurol 2013 Jun 28;73(6):705-13. Epub 2013 Jun 28.

Department of Neurology and Multiple Sclerosis Center, Wayne State University School of Medicine, Detroit, MI 48201, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ana.23938
Publisher Site
http://dx.doi.org/10.1002/ana.23938DOI Listing
June 2013

MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study.

J Neurol 2013 Apr 21;260(4):1136-46. Epub 2012 Dec 21.

Department of Neurology and Institute of Experimental Neurology, Scientific Institute H.S. Raffaele, Università Vita-Salute San Raffaele, via Olgettina 60, 20132 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-012-6775-0DOI Listing
April 2013

Characteristics of multiple sclerosis in aboriginals living in British Columbia, Canada.

Mult Scler 2012 Sep 1;18(9):1239-43. Epub 2012 Mar 1.

Faculty of Medicine, Division of Neurology, Multiple Sclerosis Program, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1352458512436595
Publisher Site
http://dx.doi.org/10.1177/1352458512436595DOI Listing
September 2012

Excitability decreasing central motor plasticity is retained in multiple sclerosis patients.

BMC Neurol 2012 Sep 13;12:92. Epub 2012 Sep 13.

Dept, of Neurology, University of Würzburg, Josef-Schneider-Str. 11, 97080, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2377-12-92DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488470PMC
September 2012

The Changes of P-glycoprotein Activity by Interferon-γ and Tumor Necrosis Factor-α in Primary and Immortalized Human Brain Microvascular Endothelial Cells.

Biomol Ther (Seoul) 2012 May;20(3):293-8

College of Pharmacy, Research Center for Cell Fate Control, Sookmyung Women's University, Seoul 140-742, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4062/biomolther.2012.20.3.293DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794526PMC
May 2012

Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009).

Mult Scler 2012 Apr 27;18(4):442-50. Epub 2011 Sep 27.

Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1352458511422097
Publisher Site
http://dx.doi.org/10.1177/1352458511422097DOI Listing
April 2012

Cladribine tablets for relapsing-remitting multiple sclerosis: Efficacy across patient subgroups from the phase III CLARITY study.

Mult Scler Relat Disord 2012 Jan 15;1(1):49-54. Epub 2011 Sep 15.

Merck Serono SA-Geneva, 9 Chemin de Mines,1202 Geneva, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2011.08.006DOI Listing
January 2012

Targeting progressive neuroaxonal injury: lessons from multiple sclerosis.

CNS Drugs 2011 Sep;25(9):783-99

Department of Neurology and Neurosurgery and Microbiology and Immunology, McGill University, Neuroimmunology Unit, Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.2165/11587820-000000
Web Search
http://link.springer.com/10.2165/11587820-000000000-00000
Publisher Site
http://dx.doi.org/10.2165/11587820-000000000-00000DOI Listing
September 2011

Functional role of ipsilateral motor areas in multiple sclerosis.

J Neurol Neurosurg Psychiatry 2011 May 27;82(5):578-83. Epub 2010 Oct 27.

Department of Neurology, University of Würzburg, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jnnp.2010.219964DOI Listing
May 2011

Analysis of the stathmin rs182455 single nucleotide promoter polymorphism in patients with multiple sclerosis.

J Neurogenet 2008 ;22(3):181-6

Neurologische Klinik, Julius-Maximilians-Universität, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/01677060802179287DOI Listing
March 2011

The natural history of secondary progressive multiple sclerosis.

J Neurol Neurosurg Psychiatry 2010 Sep 16;81(9):1039-43. Epub 2010 Jul 16.

Department of Neurology, University Medical Centre Groningen, GZ Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://jnnp.bmj.com/content/81/9/1039.full.pdf
Web Search
http://jnnp.bmj.com/cgi/doi/10.1136/jnnp.2010.208173
Publisher Site
http://dx.doi.org/10.1136/jnnp.2010.208173DOI Listing
September 2010

New perspectives in the natural history of multiple sclerosis.

Neurology 2010 Jun;74(24):2004-15

Faculty of Medicine, Division of Neurology, Multiple Sclerosis Program, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://www.neurology.org/cgi/doi/10.1212/WNL.0b013e3181e3973
Publisher Site
http://dx.doi.org/10.1212/WNL.0b013e3181e3973fDOI Listing
June 2010

Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts.

J Neurol Sci 2010 May 4;292(1-2):57-62. Epub 2010 Mar 4.

Faculty of Medicine (Neurology), Multiple Sclerosis Program, UBC Hospital, 2211 Wesbrook Mall, University of British Columbia, Vancouver, BC, Canada V6T 2B5.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2010.02.007DOI Listing
May 2010

A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.

N Engl J Med 2010 Feb 20;362(5):416-26. Epub 2010 Jan 20.

Queen Mary University London, the Blizard Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa0902533DOI Listing
February 2010

The natural history of primary progressive multiple sclerosis.

Neurology 2009 Dec;73(23):1996-2002

Faculty of Medicine, Division of Neurology, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://www.neurology.org/cgi/doi/10.1212/WNL.0b013e3181c5b47
Publisher Site
http://dx.doi.org/10.1212/WNL.0b013e3181c5b47fDOI Listing
December 2009

Concepts of induction and escalation therapy in multiple sclerosis.

Authors:
Peter Rieckmann

J Neurol Sci 2009 Feb;277 Suppl 1:S42-5

Department of Medicine, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0022-510X(09)70012-7DOI Listing
February 2009

Escalating immunotherapy of multiple sclerosis.

Ther Adv Neurol Disord 2008 Nov;1(3):181-92

Director, Multiple Sclerosis Program Division of Neurology, University of British Columbia, Vancouver, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756285608098359DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002550PMC
November 2008

Imatinib buys time for brain after stroke.

Authors:
Peter Rieckmann

Nat Med 2008 Jul;14(7):712-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm0708-712DOI Listing
July 2008

Treating multiple sclerosis with monoclonal antibodies.

Expert Rev Neurother 2008 Mar;8(3):433-55

Julius-Maximilians University, Department of Neurology, Josef-Schneider-Str. 11, 97080 Würzburg, Germany.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/14737175.8.3.433
Publisher Site
http://dx.doi.org/10.1586/14737175.8.3.433DOI Listing
March 2008

Multiple sclerosis registry in Germany: results of the extension phase 2005/2006.

Dtsch Arztebl Int 2008 Feb 15;105(7):113-9. Epub 2008 Feb 15.

Neurologisches Rehabilitationszentrum Quellenhof, Kuranlagenallee 2, Bad Wildbad, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3238/arztebl.2008.0113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696719PMC
February 2008

Interferon-beta1b in multiple sclerosis.

Expert Rev Neurother 2007 Mar;7(3):227-39

Julius-Maximilians University, Department of Neurology, Josef-Schneider-Str. 11, D-97080 Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737175.7.3.227DOI Listing
March 2007

Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells.

J Vasc Res 2007 13;44(1):51-60. Epub 2006 Dec 13.

Department of Neurology, Julius-Maximilians University, Josef-Schneider-Strasse 11, DE-97080 Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000097977DOI Listing
February 2007

Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls.

J Neuroimmunol 2006 Nov 4;180(1-2):185-92. Epub 2006 Oct 4.

Clinical Research Group for Multiple Sclerosis and Neuroimmunology, Department of Neurology, Julius-Maximilians Universität Würzburg, 97080 Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2006.08.008DOI Listing
November 2006

Socio-economic aspects of neuroimmunological diseases.

Authors:
Peter Rieckmann

J Neurol 2006 Sep;253 Suppl 5:V87-90

Clinical Research Group for Multiple Sclerosis and Neuroimmunology, Dept. of Neurology, University of Wuerzburg, Josef-Schneider-Str. 11, 97080, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-006-5015-xDOI Listing
September 2006

[Practical advice for a safe, effective and well tolerated therapy of multiple sclerosis].

MMW Fortschr Med 2006 May;Spec no. 2:49-50, 52-3

Neurologische Universitätsklinik, Julius-Maximilians Universität Würzburg.

View Article

Download full-text PDF

Source
May 2006

Isolation and culture of microvascular endothelial cells from gliomas of different WHO grades.

J Neurooncol 2006 Jan;76(1):39-48

Department of Neurosurgery, Klinikum Grosshadern, Ludwig-Maximilians-University Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-005-3674-6DOI Listing
January 2006

Subcutaneous interferon-beta injections in patients with multiple sclerosis initiate inflammatory skin reactions by local chemokine induction.

J Neuroimmunol 2005 Nov 26;168(1-2):175-82. Epub 2005 Aug 26.

Department of Neurology, Julius-Maximilians-University, Josef-Schneider-Str. 11, D-97080 Würzburg, Germany.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016557280500310
Publisher Site
http://dx.doi.org/10.1016/j.jneuroim.2005.07.011DOI Listing
November 2005

Association of a common polymorphism in the promoter of UCP2 with susceptibility to multiple sclerosis.

J Mol Med (Berl) 2005 Oct 15;83(10):806-11. Epub 2005 Jul 15.

Department of Immunology, University of Rostock, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00109-005-0661-5DOI Listing
October 2005

Neurodegeneration and clinical relevance for early treatment in multiple sclerosis.

Authors:
Peter Rieckmann

Int MS J 2005 Aug;12(2):42-51

Department of Neurology, Julius-Maximilians University of Würzburg, Neurologische Universitätsklinik und Poliklinik, Josef-Schneider-Str. 11, Würzburg 97080, Germany.

View Article

Download full-text PDF

Source
August 2005

A PD-1 polymorphism is associated with disease progression in multiple sclerosis.

Ann Neurol 2005 Jul;58(1):50-7

Clinical Research Group for Multiple Sclerosis and Neuroimmunology, Department of Neurology, Bayerische Julius-Maximilians Universität, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.20514DOI Listing
July 2005

The role of the polio virus receptor and the herpesvirus entry mediator B genes for the development of MS.

J Neuroimmunol 2004 Nov;156(1-2):171-7

Clinical Neuroimmunology Group, Department of Neurology, Philipps-University, Marburg, Germany; Department of Neurology, Heinrich-Heine-University, Duesseldorf, Germany.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016557280400226
Publisher Site
http://dx.doi.org/10.1016/j.jneuroim.2004.07.001DOI Listing
November 2004

Interferon-beta induces transient systemic IP-10/CXCL10 chemokine release in patients with multiple sclerosis.

J Neuroimmunol 2004 Nov;156(1-2):195-203

Clinical Research Unit for Multiple Sclerosis and Neuroimmunology, Department of Neurology, Julius-Maximilians-University, Josef-Schneider-Str. 11, D-97080 Würzburg, Germany.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016557280400273
Publisher Site
http://dx.doi.org/10.1016/j.jneuroim.2004.07.016DOI Listing
November 2004

Evaluation of diagnostic relevance of mRNA levels in peripheral blood: predictive value for mortality in hemodialysis patients.

Cytokine 2004 Sep;27(6):166-72

German Diabetes Centre, German Diabetes Research Institute at the Heinrich-Heine-University Düsseldorf, Auf'm Hennekamp 65, 40225 Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S104346660400180
Publisher Site
http://dx.doi.org/10.1016/j.cyto.2004.05.006DOI Listing
September 2004

Improving MS patient care.

Authors:
Peter Rieckmann

J Neurol 2004 Sep;251 Suppl 5:v69-v73

Clinical Research Unit for Multiple Sclerosis and Neuroimmunology, Department of Neurology, Julius-Maximilians University of Würzburg, Josef-Schneider-Str. 11, 97080, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-004-1511-zDOI Listing
September 2004

The blood-brain barrier as target of multiple sclerosis research and therapy. Report of an international scientific meeting, Würzburg, January 23/24, 2004.

J Neuroimmunol 2004 Jul;152(1-2):1-4

Clinical Research Group for Multiple Sclerosis and Neuroimmunology, Department of Neurology, University of Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2004.03.014DOI Listing
July 2004

Health outcomes in multiple sclerosis.

Curr Opin Neurol 2004 Jun;17(3):257-61

Department of Neurology and Clinical Research Group for Neuroimmunology, Julius Maximilians Universität Würzburg, Würzburg, Germany.

View Article

Download full-text PDF

Source
June 2004

Cytokine mRNA expression in patients with multiple sclerosis and fatigue.

Mult Scler 2004 Apr;10(2):165-9

Department of Neurology, Julius-Maximilians University of Würzburg, Josef-Schneider-Strasse 11, D-97080 Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1191/1352458504ms991oaDOI Listing
April 2004

Cytokine mRNA expression patterns in the disease course of female adolescents with anorexia nervosa.

Psychoneuroendocrinology 2004 Jan;29(1):13-20

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0306-4530(02)00131-2DOI Listing
January 2004

Early intervention in multiple sclerosis : better outcomes for patients and society?

Drugs 2003 ;63(15):1525-33

Department of Neurology and Clinical Research Group for Neuroimmunology, Julius-Maximilians University, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00003495-200363150-00001DOI Listing
November 2003

Building up the blood-brain barrier.

Nat Med 2003 Jul;9(7):828-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm0703-828DOI Listing
July 2003

Influence of VEGF-R2 inhibition on MMP secretion and motility of microvascular human cerebral endothelial cells (HCEC).

J Neurooncol 2003 May;62(3):221-31

Department of Neurosurgery, University of Wuerzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1023335732264DOI Listing
May 2003

Production of IL-12 and IL-18 in human dendritic cells upon infection by Listeria monocytogenes.

FEMS Immunol Med Microbiol 2003 Apr;35(3):255-62

Department of Dermatology, University of Würzburg, 97080 Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0928-8244(02)00470-4DOI Listing
April 2003

Inflammation in multiple sclerosis: the good, the bad, and the complex.

Lancet Neurol 2002 Dec;1(8):499-509

Department of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.

View Article

Download full-text PDF

Source
December 2002